MX9505113A - Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan. - Google Patents

Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan.

Info

Publication number
MX9505113A
MX9505113A MX9505113A MX9505113A MX9505113A MX 9505113 A MX9505113 A MX 9505113A MX 9505113 A MX9505113 A MX 9505113A MX 9505113 A MX9505113 A MX 9505113A MX 9505113 A MX9505113 A MX 9505113A
Authority
MX
Mexico
Prior art keywords
derivatives
fluoroquinolonates
cephalosporine
pharmaceutical compositions
present
Prior art date
Application number
MX9505113A
Other languages
English (en)
Inventor
Miguel Angel Corpi Constantino
Juan Azuara Salas
Original Assignee
Aranda Lab Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aranda Lab Sa De Cv filed Critical Aranda Lab Sa De Cv
Priority to MX9505113A priority Critical patent/MX9505113A/es
Priority to AU43136/96A priority patent/AU4313696A/en
Priority to PCT/IB1996/000012 priority patent/WO1997020849A1/en
Priority to ZA966266A priority patent/ZA966266B/xx
Priority to CO96041573A priority patent/CO4700467A1/es
Publication of MX9505113A publication Critical patent/MX9505113A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados de los Cephalosporín-Fluoroquinolonatos y con las composiciones farmacéuticas con una actividad antibacteriana, antimicoplásmica y antiviral que los contengan. Los derivados de los cephalosporín fluro-quinolonatos de esta invencion son en particular derivados del ácido 7-aminoceph-3-em-4-carboxílico con derivados de la 6-Fluoroquinolona en los que los grupos Cephem y 6-Fluoroquinolona están unidos entre sí a través de la formacion de una sal de amonio. Estos compuestos se designan de aquí en adelante como derivados de los cepha-fluoroquinolonatos. Teniendo la ventaja de ser un proceso más simple y economico con mejores rendimientos y con la gran ventaja de reducir en una forma más importante el manejo y uso de productos químicos peligrosos reduciendo también las posibilidades de contaminacion del ambiente y agua.
MX9505113A 1995-12-07 1995-12-07 Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan. MX9505113A (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MX9505113A MX9505113A (es) 1995-12-07 1995-12-07 Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan.
AU43136/96A AU4313696A (en) 1995-12-07 1996-01-08 Cephalosporin fluoroquinolonate derivatives and pharmaceutical compositions containing them
PCT/IB1996/000012 WO1997020849A1 (en) 1995-12-07 1996-01-08 Cephalosporin fluoroquinolonate derivatives and pharmaceutical compositions containing them
ZA966266A ZA966266B (en) 1995-12-07 1996-07-24 Cephalosporin fluoroquinolonate derivatives
CO96041573A CO4700467A1 (es) 1995-12-07 1996-08-06 Derivados de cephalosporin fluoroquinolonatos y composicio- nes farmaceuticas que los contengan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9505113A MX9505113A (es) 1995-12-07 1995-12-07 Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan.

Publications (1)

Publication Number Publication Date
MX9505113A true MX9505113A (es) 1997-06-28

Family

ID=19744891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9505113A MX9505113A (es) 1995-12-07 1995-12-07 Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan.

Country Status (5)

Country Link
AU (1) AU4313696A (es)
CO (1) CO4700467A1 (es)
MX (1) MX9505113A (es)
WO (1) WO1997020849A1 (es)
ZA (1) ZA966266B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202013005992U1 (de) 2013-07-04 2013-08-08 Toyochem Laboratories Pharmazeutische Zusammensetzung umfassend Ofloxacin und Cefuroxim

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA874696B (en) * 1986-07-03 1988-01-04 F. Hoffmann-La Roche & Co. Aktiengesellschaft Acyl derivatives
EP0492277A3 (en) * 1990-12-20 1992-10-14 F. Hoffmann-La Roche Ag Cephalosporin derivatives
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren

Also Published As

Publication number Publication date
WO1997020849A1 (en) 1997-06-12
ZA966266B (en) 1997-03-26
CO4700467A1 (es) 1998-12-29
AU4313696A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
UA37181C2 (uk) ГІДРОХЛОРИД 7-<font face="Symbol">b</font>-[(Z)-2-(2-АМІНО-4-ТІАЗОЛІЛ)-3-ГІДРОКСИІМІНОАЦЕТА- МІДО]-3-(1,2,3-ТРИАЗОЛ-4-ІЛ)ТІОМЕТИЛТІО-3-ЦЕФЕМ-4-КАРБОНОВОЇ КИСЛОТИ АБО ЙОГО ГІДРАТИ, ЩО МАЮТЬ АНТИБАКТЕРІАЛЬНУ ДІЮ, ФАРМАЦЕВТИЧНА АНТИБАКТЕРІАЛЬНА КОМПОЗИЦІЯ, СПОСІБ ПРИГНІЧЕННЯ РОЗВИТКУ БАКТЕРІЙ, СПОСІБ ЛІКУВАННЯ БАКТЕРІАЛЬНИХ ІНФЕКЦІЙ
MY115416A (en) Quinolone-and naphthyridone-carboxylic acid derivatives
IT1244643B (it) Composizioni di calcestruzzo da spruzzare
HUT67691A (en) 7-(substituted)-8-(substituted)-9-[(substituted-glycyl)amido]6-demethyl-6-deoxytetracyclines, pharmaceutical compositions containing them and process to prepare them
AU4718496A (en) Use of aerogels in agriculture
ES8507535A1 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
NL930048I2 (nl) Nieuwe derivaten van bicyclische aminozuren, werkwijze voor hun bereiding, deze stoffen bevattende middelen en hun toepassing alsmede nieuwe bicyclische aminozuren als tussentrappen en werkwijzen voor hun bereiding.
UA42734C2 (uk) Водорозчинна сіль німеcуліду, водний розчин солі німеcуліду, композиції на основі німеcуліду, спосіб отримання водорозчинної солі німеcуліду та фармацевтична композиція для лікування запалювальних захворювань
ZA956709B (en) Ionene polymers containing biologically-active anions
EG14227A (en) N-phenoxyalkyl imidazoles as selective infibitors of the thermoboxane synthetase enzyme,pharmaceutical compositions thereof and process for their preparation
AU563591B2 (en) Pyrazolo/4,3-c/pyridines
MA23490A1 (fr) Derives de lipopeptide, procede pour leur preparation, composition les contenant et leur utilisation .
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
ATE96167T1 (de) Verfahren zur kristallisation von enzymen.
IE811513L (en) Benzisoselenazolones
AU5976494A (en) Oxidising agents
FI962656A0 (fi) Menetelmä stabiloida partikkelimainen alkalimetalliperkarbonaatti
JO1406B1 (en) Chemical compounds
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
DE59108298D1 (de) 7-(2,7-Diazabicyclo[3,3.0]octyl)-3-chinolon- und -naphthyridoncarbonsäure-Derivate
MX9505113A (es) Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan.
IL71319A (en) (1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the same
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES8102058A1 (es) Procedimiento para la obtencion de suspensiones acuosas de zeolita estables
IE801677L (en) An antimycotic vaginal tablet

Legal Events

Date Code Title Description
FA Abandonment or withdrawal